JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

Human alpha-1-Acid Glycoprotein (Orosomucoid, AGP) AssayMax ELISA Kit

Human alpha-1-Acid Glycoprotein (Orosomucoid, AGP) AssayMax ELISA Kit

Move your mouse over image or click to enlarge

Human alpha-1-Acid Glycoprotein (Orosomucoid, AGP) AssayMax ELISA Kit

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.

View Datasheet

Cat#	Size	Price	Qty	Buy
EG5001-1	96 Well Plate	£260.00

Additional Information

Property	Value or Rating
Manufacturer	Assaypro, LLC.
Product Type	AssayMax™ ELISA Kits
Species	Human
Assay Format	Competitive ELISA
Product Size	96 Well Plate
Range	0.125-4 ug/ml
Plex Number	1
Storage	Refer to component labels for details
Entrez Gene	5004
Omim	138600
UniProt	P02763
UniGene	Hs.522356
Special Notes	For Research Use Only, Not To Be Used For Diagnostic Purposes
References	* Chance M et al. (2011) PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR RENAL DISORDERS. United States Patent Application 20120329071 * Ofotokun I et al. (2011) Immune activation mediated change in alpha-1-Acid glycoprotein: impact on total and free lopinavir plasma exposure. J Clin Pharmacol. 51(11):1539-48 * Alfadda AA et al. (2012) Orosomucoid serum concentrations and fat depot-specific mRNA and protein expression in humans. Mol Cells. 33(1):35-41 * Schlatzer D et al. (2012) Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. Diabetes Care. 35(3):549-55. Epub 2012 Jan 11 * Lv M et al. (2013) Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation. PLoS One 8(3):e58735 * Alfadda AA (2014) Circulating Adipokines in Healthy versus Unhealthy Overweight and Obese Subjects. Int J Endocrinol. 2014:170434. doi: 10.1155/2014/170434. Epub 2014 Jan 16 * Martos-Moreno GA et al. (2014) Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children. Int J Pediatr Endocrinol. 2014(1):9. doi: 10.1186 * Omran M et al. (2016) A Prospective Pharmacokinetic Study of Docetaxel in Breast Cancer Patients in Relation to CYP3A4 Activity. Clin Pharmacol Biopharm 5:2 (alpha-1-acid Glycoprotein Kit). * Wrzesniak M et al. (2016) The Influence of Tobacco Smoke on Protein and Metal Levels in the Serum of Women during Pregnancy. PLoS One. 11(8):e0161342 * Rodgers P (2017) Developing minimally invasive, tools and technologies for high throughput, low cost molecular assays for the early diagnosis of schizophrenia and other psychiatric disorders. Cordis, SchizDX Report Summary, Project ID: 223427, Record Number: 196528 " title=" * Chance M et al. (2011) PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR RENAL DISORDERS. United States Patent Application 20120329071 * Ofotokun I et al. (2011) Immune activation mediated change in alpha-1-Acid glycoprotein: impact on total and free lopinavir plasma exposure. J Clin Pharmacol. 51(11):1539-48 * Alfadda AA et al. (2012) Orosomucoid serum concentrations and fat depot-specific mRNA and protein expression in humans. Mol Cells. 33(1):35-41 * Schlatzer D et al. (2012) Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. Diabetes Care. 35(3):549-55. Epub 2012 Jan 11 * Lv M et al. (2013) Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation. PLoS One 8(3):e58735 * Alfadda AA (2014) Circulating Adipokines in Healthy versus Unhealthy Overweight and Obese Subjects. Int J Endocrinol. 2014:170434. doi: 10.1155/2014/170434. Epub 2014 Jan 16 * Martos-Moreno GA et al. (2014) Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children. Int J Pediatr Endocrinol. 2014(1):9. doi: 10.1186 * Omran M et al. (2016) A Prospective Pharmacokinetic Study of Docetaxel in Breast Cancer Patients in Relation to CYP3A4 Activity. Clin Pharmacol Biopharm 5:2 (alpha-1-acid Glycoprotein Kit). * Wrzesniak M et al. (2016) The Influence of Tobacco Smoke on Protein and Metal Levels in the Serum of Women during Pregnancy. PLoS One. 11(8):e0161342 * Rodgers P (2017) Developing minimally invasive, tools and technologies for high throughput, low cost molecular assays for the early diagnosis of schizophrenia and other psychiatric disorders. Cordis, SchizDX Report Summary, Project ID: 223427, Record Number: 196528 " target="_blank"> * Chance M et al. (2011) PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR RENAL DISORDERS. United States Patent Application 20120329071 * Ofotokun I et al. (2011) Immune activation mediated change in alpha-1-Acid glycoprotein: impact on total and free lopinavir plasma exposure. J Clin Pharmacol. 51(11):1539-48 * Alfadda AA et al. (2012) Orosomucoid serum concentrations and fat depot-specific mRNA and protein expression in humans. Mol Cells. 33(1):35-41 * Schlatzer D et al. (2012) Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. Diabetes Care. 35(3):549-55. Epub 2012 Jan 11 * Lv M et al. (2013) Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation. PLoS One 8(3):e58735 * Alfadda AA (2014) Circulating Adipokines in Healthy versus Unhealthy Overweight and Obese Subjects. Int J Endocrinol. 2014:170434. doi: 10.1155/2014/170434. Epub 2014 Jan 16 * Martos-Moreno GA et al. (2014) Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children. Int J Pediatr Endocrinol. 2014(1):9. doi: 10.1186 * Omran M et al. (2016) A Prospective Pharmacokinetic Study of Docetaxel in Breast Cancer Patients in Relation to CYP3A4 Activity. Clin Pharmacol Biopharm 5:2 (alpha-1-acid Glycoprotein Kit). * Wrzesniak M et al. (2016) The Influence of Tobacco Smoke on Protein and Metal Levels in the Serum of Women during Pregnancy. PLoS One. 11(8):e0161342 * Rodgers P (2017) Developing minimally invasive, tools and technologies for high throughput, low cost molecular assays for the early diagnosis of schizophrenia and other psychiatric disorders. Cordis, SchizDX Report Summary, Project ID: 223427, Record Number: 196528

Related Documents